900 Walnut Street
Second Floor
Philadelphia, PA 19107
(215) 955-2243
(215) 955-2060 fax
Second Floor
Philadelphia, PA 19107
(215) 955-2243
(215) 955-2060 fax
Most Recent Peer-reviewed Publications
- Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials
- Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension
- Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study
- Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice”
- Eptinezumab for the prevention of chronic migraine: Efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study
Medical School
University of Pennsylvania School of Medicine - 1967
Residency
Hospital of University of Pennsylvania (HUP) 1972 - 1975
Fellowship
National Institute of Health
Board Certification
Neurology
Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital
Research and Clinical Interests
Headache;
Migraine;
Clinical trials.
Other Expertise
Headache guidelines